Artificial intelligence has developed a potential cancer treatment

In a new study, researchers at the University of Toronto worked with Insilico Medicine to develop a potential treatment for hepatocellular carcinoma (HCC) – an aggressive form of liver cancer that occurs when a tumour grows on the organ.

The AI discovered a previously unknown treatment pathway and designed a 'novel hit molecule' that is capable of binding to the target.

The system is also able to predict a patient's survival rate using doctors' notes.

Insilico Medicine CEO Alex Zhavoronkov said: "While the world was fascinated with advances in generative AI in art and language, our generative AI algorithms managed to design potent inhibitors of a target with an AlphaFold-derived structure."

For feedback: contact the Editorial Department at onlinefeedback@gleanerjm.com.